Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 24 11:41AM ET
8.15
Dollar change
-0.35
Percentage change
-4.12
%
Index- P/E- EPS (ttm)-18.38 Insider Own1.66% Shs Outstand3.20M Perf Week-12.37%
Market Cap26.08M Forward P/E- EPS next Y-3.15 Insider Trans- Shs Float3.15M Perf Month-20.10%
Income-37.58M PEG- EPS next Q-2.79 Inst Own40.70% Short Float1.26% Perf Quarter-9.54%
Sales0.00M P/S- EPS this Y44.35% Inst Trans47.01% Short Ratio4.24 Perf Half Y-1.81%
Book/sh14.30 P/B0.57 EPS next Y73.46% ROA-67.75% Short Interest0.04M Perf Year-33.00%
Cash/sh8.53 P/C0.96 EPS next 5Y29.90% ROE-80.66% 52W Range4.50 - 16.19 Perf YTD-13.30%
Dividend Est.- P/FCF- EPS past 5Y- ROI-123.77% 52W High-49.66% Beta0.87
Dividend TTM- Quick Ratio5.18 Sales past 5Y-33.33% Gross Margin77.27% 52W Low81.11% ATR (14)0.77
Dividend Ex-Date- Current Ratio5.18 EPS Y/Y TTM4.52% Oper. Margin0.00% RSI (14)33.50 Volatility9.21% 8.73%
Employees42 Debt/Eq0.09 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price33.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q40.76% Payout- Rel Volume0.53 Prev Close8.50
Sales Surprise- EPS Surprise0.24% Sales Q/Q- EarningsMay 08 AMC Avg Volume9.36K Price8.15
SMA20-16.64% SMA50-20.63% SMA200-14.47% Trades Volume1,833 Change-4.12%
Date Action Analyst Rating Change Price Target Change
Oct-11-21Initiated BofA Securities Buy $11
Sep-15-21Initiated Guggenheim Buy $20
Sep-07-21Initiated Stifel Buy $19
Jun-12-24 08:30AM
Jun-10-24 08:30AM
Jun-04-24 08:30AM
May-09-24 08:30AM
May-08-24 11:55PM
04:05PM Loading…
04:05PM
Apr-14-24 12:52PM
Apr-03-24 08:40AM
Apr-01-24 08:30AM
08:30AM
Jan-18-24 09:58AM
08:30AM
Dec-14-23 05:52AM
05:51AM
Nov-08-23 04:05PM
04:05PM Loading…
Aug-09-23 04:05PM
Jun-05-23 08:30AM
May-10-23 04:05PM
Apr-05-23 08:30AM
Mar-28-23 04:59AM
Mar-22-23 04:01PM
Mar-20-23 04:30PM
Jan-04-23 04:41PM
Nov-14-22 04:30PM
Oct-10-22 08:00AM
Oct-06-22 08:00AM
Sep-26-22 08:00AM
Aug-11-22 08:00AM
Jun-27-22 10:34AM
Jun-13-22 08:00AM
08:00AM Loading…
May-24-22 08:00AM
May-18-22 08:00AM
May-16-22 08:00AM
May-11-22 08:00AM
May-05-22 08:00AM
May-02-22 08:00AM
Mar-24-22 08:00AM
Jan-20-22 09:00AM
Jan-10-22 08:00AM
Jan-05-22 08:00AM
Nov-15-21 04:00PM
08:00AM
08:00AM
Nov-11-21 10:51AM
Nov-05-21 08:00AM
Oct-05-21 04:30PM
Sep-23-21 08:30AM
Aug-11-21 05:30PM
Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLUMN GROUP III GP, LP10% OwnerApr 04 '24Buy15.50193,5482,999,994332,885Apr 08 04:23 PM
Kutzkey TimDirectorApr 04 '24Buy15.50193,5482,999,994332,885Apr 08 04:24 PM